Autoimmune Stem-like CD8 T cells in Type 1 Diabetes
1 型糖尿病中的自身免疫干细胞样 CD8 T 细胞
基本信息
- 批准号:10736295
- 负责人:
- 金额:$ 91.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-08 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:Antigen-Presenting CellsAutoimmuneAutoimmune DiseasesBar CodesBeta CellBloodCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell CommunicationCellsComplexDNAEquilibriumGene Expression ProfileGenesGoalsHomingHumanImageInbred NOD MiceIndividualInfiltrationInsulinInsulin-Dependent Diabetes MellitusKnowledgeMaintenanceMalignant NeoplasmsMediatingMethodsModelingMolecularMolecular TargetMusMyeloid CellsNatureNon obeseOrgan DonorPancreasPathway interactionsPatientsPatternPopulationPreventionPrevention strategyRiskRoleSignal TransductionSiteStromal CellsT cell differentiationT cell receptor repertoire sequencingT cell responseT cell transcription factor 1T-LymphocyteTestingTherapeutic InterventionWNT Signaling Pathwayadult stem cellcellular targetingchemokinechronic infectionclinical translationclinically relevantdiabetes pathogenesisdiabeticdiabetogenicexperimental studyhuman diseaseimmune cell infiltrateimmunological synapseinnovationinnovative technologiesinsightlymph nodesmigrationmouse modelmultiplexed imagingnovelperipheral bloodpopulation basedpreventprogenitorprogramsreceptorself renewing cellself-renewalsingle-cell RNA sequencingstemstemnesstranscription factor
项目摘要
PROJECT SUMMARY
T cell–mediated autoimmune diseases result from the breakdown of tolerance mechanisms in self-reactive CD8
T cells. However, many aspects of autoimmune CD8 T cell differentiation remain enigmatic, including where and
how autoimmune T cell populations arise and are maintained and what molecular programs define autoimmune
T cell states. Type I diabetes (T1D) is a CD8 T cell–mediated autoimmune disease; T1D pathogenesis is complex
and involves immune infiltration of the pancreas and destruction of insulin-producing β cells by CD8 T cells. The
non-obese diabetic (NOD) mouse model is a clinically relevant model of T1D, which shares many features with
human disease. Utilizing the NOD model, we investigate autoimmune β cell-specific CD8 T cells differentiation
state dynamics over the course of T1D. We identified a stem-like progenitor CD8 T cell population in the
pancreatic lymph node that self-renews and gives rise to differentiated progeny, which migrate to the pancreas
and destroy β cells. The goal of this application is to generate a deep mechanistic understanding of the niche-
dependent intercellular interactions and signals in the pancreatic lymph node that maintain the autoimmune
stem-like progenitor T cell pool and regulate differentiation, and to use this knowledge to develop strategies for
therapeutic interventions. We will (i) employ innovative imaging and sequencing approaches to identify the
spatial organization of pancreatic lymph node niches that determine diabetogenic T cell responses, (ii) determine
the functional roles of key transcription factors controlling autoimmune T cell differentiation and test whether
deletion or enforced expression of these transcription factors can alter autoimmune T cell states, and (iii)
investigate autoimmune β cell-specific CD8 T cell states in human pancreatic lymph nodes and pancreas from
organ donors with T1D. If successful, the proposed studies will provide important insights into autoimmune β
cell-specific CD8 T cell programming in mouse and human T1D and could yield promising molecular and cellular
targets for the prevention or treatment of T1D and other T cell-mediated autoimmune diseases.
项目摘要
T细胞介导的自身免疫性疾病是由于自身反应性CD 8
T细胞。然而,自身免疫性CD 8 T细胞分化的许多方面仍然是谜,包括在哪里和
自身免疫性T细胞群是如何产生和维持的,以及什么样的分子程序定义了自身免疫性T细胞群
T细胞状态。I型糖尿病(T1 D)是一种CD 8 T细胞介导的自身免疫性疾病,发病机制复杂
并且涉及胰腺的免疫浸润和CD 8 T细胞对产生胰岛素的β细胞的破坏。的
非肥胖糖尿病(NOD)小鼠模型是T1 D的临床相关模型,其与T1 D小鼠模型共享许多特征。
人类疾病利用NOD模型,我们研究了自身免疫性β细胞特异性CD 8 T细胞分化
在T1 D过程中的状态动态。我们发现,干细胞样祖细胞CD 8 T细胞群在CD 8 T细胞中,
自我更新并产生迁移到胰腺的分化后代的胰腺淋巴结
破坏β细胞这个应用程序的目标是产生一个深刻的机械理解的利基-
胰腺淋巴结中的依赖性细胞间相互作用和信号,
干细胞样祖细胞T细胞库和调节分化,并利用这些知识来开发策略,
治疗干预。我们将(i)采用创新的成像和测序方法来识别
胰腺淋巴结小生境的空间组织,其决定致糖尿病性T细胞应答,(ii)确定
控制自身免疫性T细胞分化的关键转录因子的功能作用,并测试是否
这些转录因子的缺失或强制表达可以改变自身免疫性T细胞状态,以及(iii)
研究人胰腺淋巴结和胰腺中自身免疫性β细胞特异性CD 8 T细胞状态
T1 D的器官捐献者如果成功的话,这些研究将为自身免疫性β
在小鼠和人T1 D中的细胞特异性CD 8 T细胞编程,并且可以产生有前景的分子和细胞生物学特性。
用于预防或治疗T1 D和其他T细胞介导的自身免疫性疾病的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrea Schietinger其他文献
Andrea Schietinger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrea Schietinger', 18)}}的其他基金
TOX-driven CD8 T cell differentiation and dysfunction in tumors
TOX驱动的肿瘤中CD8 T细胞分化和功能障碍
- 批准号:
10586679 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Spatiotemporal regulation of T cell fate decisions in cancer
癌症中 T 细胞命运决定的时空调控
- 批准号:
9350820 - 财政年份:2017
- 资助金额:
$ 91.07万 - 项目类别:
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesis
早期肿瘤发生中肿瘤特异性 T 细胞状态动态和异质性
- 批准号:
9980808 - 财政年份:2016
- 资助金额:
$ 91.07万 - 项目类别:
Molecular and Epigenetic Programs Underlying T cell Tolerance to Tumor Antigens
T 细胞对肿瘤抗原耐受的分子和表观遗传程序
- 批准号:
9205491 - 财政年份:2015
- 资助金额:
$ 91.07万 - 项目类别:
Molecular and Epigenetic Programs Underlying T cell Tolerance to Tumor Antigens
T 细胞对肿瘤抗原耐受的分子和表观遗传程序
- 批准号:
8975841 - 财政年份:2015
- 资助金额:
$ 91.07万 - 项目类别:
Molecular and Epigenetic Programs Underlying T cell Tolerance to Tumor Antigens
T 细胞对肿瘤抗原耐受的分子和表观遗传程序
- 批准号:
8424846 - 财政年份:2013
- 资助金额:
$ 91.07万 - 项目类别:
Molecular and Epigenetic Programs Underlying T cell Tolerance to Tumor Antigens
T 细胞对肿瘤抗原耐受的分子和表观遗传程序
- 批准号:
8601299 - 财政年份:2013
- 资助金额:
$ 91.07万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 91.07万 - 项目类别: